DiaMedica Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Accrued Liabilities

6 Months Ended

Jun. 30, 2021

8.	Accrued Liabilities

Accrued liabilities consisted of the following (in thousands):

	June 30, 2021		December 31, 2020
Accrued clinical study costs	$	638	$	13
Accrued research and other professional fees		296		360
Accrued compensation		191		483
Accrued taxes and other liabilities		7		8
Total accrued liabilities	$	1,132	$	864